Home / Congress Presentations / PNH / International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023
Landing
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023
Early Hemoglobin and Quality-of-Life Trends from OPERA: a Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria
Understanding the real-world clinical effectiveness of pegcetacoplan for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.